Jeffrey Stuart Peters - Mar 10, 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Senior VP and General Counsel
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Stock symbol
MGNX
Transactions as of
Mar 10, 2023
Transactions value $
-$32,393
Form type
4
Date filed
3/14/2023, 04:22 PM
Previous filing
Feb 24, 2023
Next filing
Feb 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Sale -$32.4K -5.37K -100% $6.03 0 Mar 10, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.
F2 This transaction was executed in multiple trades at prices ranging from $5.80 to $6.18. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.